[HTML] mdpi.com

[HTML][HTML] Limitations in the design of chimeric antigen receptors for cancer therapy

S Stoiber, BL Cadilha, MR Benmebarek, S Lesch… - Cells, 2019 - mdpi.com
Cancer therapy has entered a new era, transitioning from unspecific chemotherapeutic
agents to increasingly specific immune-based therapeutic strategies. Among these, chimeric …
被引用次数：167 相关文章

Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy

S Stoiber, BL Cadilha, MR Benmebarek, S Lesch… - Cells, 2019 - search.proquest.com
Cancer therapy has entered a new era, transitioning from unspecific chemotherapeutic
agents to increasingly specific immune-based therapeutic strategies. Among these, chimeric …

Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy

S Stoiber, BL Cadilha, MR Benmebarek, S Lesch… - 2019 - agris.fao.org
Cancer therapy has entered a new era, transitioning from unspecific chemotherapeutic
agents to increasingly specific immune-based therapeutic strategies. Among these, chimeric …
[PDF] semanticscholar.org

[PDF][PDF] Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy

S Stoiber, BL Cadilha, MR Benmebarek, S Lesch… - pdfs.semanticscholar.org
Cancer therapy has entered a new era, transitioning from unspecific chemotherapeutic
agents to increasingly specific immune-based therapeutic strategies. Among these, chimeric …

Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy.

S Stoiber, BL Cadilha, MR Benmebarek, S Lesch… - Cells, 2019 - europepmc.org
Cancer therapy has entered a new era, transitioning from unspecific chemotherapeutic
agents to increasingly specific immune-based therapeutic strategies. Among these, chimeric …

Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy

S Stoiber, BL Cadilha, MR Benmebarek, S Lesch… - Cells, 2019 - pubmed.ncbi.nlm.nih.gov
Cancer therapy has entered a new era, transitioning from unspecific chemotherapeutic
agents to increasingly specific immune-based therapeutic strategies. Among these, chimeric …

Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy

S Stoiber, BL Cadilha, MR Benmebarek, S Lesch… - Cells, 2019 - cir.nii.ac.jp
抄録< jats: p> Cancer therapy has entered a new era, transitioning from unspecific
chemotherapeutic agents to increasingly specific immune-based therapeutic strategies …

Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy.

S Stoiber, BL Cadilha, MR Benmebarek… - Cells (2073 …, 2019 - search.ebscohost.com
Cancer therapy has entered a new era, transitioning from unspecific chemotherapeutic
agents to increasingly specific immune-based therapeutic strategies. Among these, chimeric …
[HTML] nih.gov

[HTML][HTML] Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy

S Stoiber, BL Cadilha, MR Benmebarek, S Lesch… - Cells, 2019 - ncbi.nlm.nih.gov
Cancer therapy has entered a new era, transitioning from unspecific chemotherapeutic
agents to increasingly specific immune-based therapeutic strategies. Among these, chimeric …

Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy

S Stoiber, BL Cadilha, MR Benmebarek, S Lesch… - Cells, 2019 - epub.ub.uni-muenchen.de
Cancer therapy has entered a new era, transitioning from unspecific chemotherapeutic
agents to increasingly specific immune-based therapeutic strategies. Among these, chimeric …